Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spitz

Showing results (71-80 of 240) with videos related to

Pageof 24
Sort By:
Human Reproduction Update|March 26, 2005
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsNathalie Chabbert-Buffet, Geri Meduri, Philippe Bouchard, et al.
Clinical Endocrinology|August 1, 1978
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemiaH Landau, I M Spitz, G Cividalli, et al.
Immunology|March 1, 1985
Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytesM Spitz, A Gearing, M Callus, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1979
Prolactin nonresponsiveness to arginine in diabetes mellitusD Le Roith, M Shapiro, K Jabotinsky, et al.
Israel Journal of Medical Sciences|July 1, 1980
Hypothalamic-pituitary function in the Bardet-Biedl syndromeD Leroith, Y Farkash, J Bar-Ziev, et al.
The New England Journal of Medicine|May 1, 1998
Early pregnancy termination with mifepristone and misoprostol in the United StatesI M Spitz, C W Bardin, L Benton, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1989
Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in womenI M Spitz, D Shoupe, R Sitruk-Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulationH B Croxatto, A M Salvatierra, C Romero, et al.
The Journal of Endocrinology|January 1, 1982
Gonadotrophin, testosterone and prolactin interrelationships in cadmium-treated ratsE A Zylber-Haran, H Gershman, E Rosenmann, et al.
Metabolism: Clinical and Experimental|March 1, 1997
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatmentO Heikinheimo, S Ranta, S Grunberg, et al.
Pageof 24

Showing results (71-80 of 240) with videos related to

Sort By:
Pageof 24
Human Reproduction Update|March 26, 2005
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsNathalie Chabbert-Buffet, Geri Meduri, Philippe Bouchard, et al.
Clinical Endocrinology|August 1, 1978
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemiaH Landau, I M Spitz, G Cividalli, et al.
Immunology|March 1, 1985
Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytesM Spitz, A Gearing, M Callus, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1979
Prolactin nonresponsiveness to arginine in diabetes mellitusD Le Roith, M Shapiro, K Jabotinsky, et al.
Israel Journal of Medical Sciences|July 1, 1980
Hypothalamic-pituitary function in the Bardet-Biedl syndromeD Leroith, Y Farkash, J Bar-Ziev, et al.
The New England Journal of Medicine|May 1, 1998
Early pregnancy termination with mifepristone and misoprostol in the United StatesI M Spitz, C W Bardin, L Benton, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1989
Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in womenI M Spitz, D Shoupe, R Sitruk-Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulationH B Croxatto, A M Salvatierra, C Romero, et al.
The Journal of Endocrinology|January 1, 1982
Gonadotrophin, testosterone and prolactin interrelationships in cadmium-treated ratsE A Zylber-Haran, H Gershman, E Rosenmann, et al.
Metabolism: Clinical and Experimental|March 1, 1997
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatmentO Heikinheimo, S Ranta, S Grunberg, et al.
Pageof 24